Physician profile
Stephen Bradle Arnold
NPI 1023021680
$1,683.00
in general payments reported to CMS, 2019-2025
19 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $205 · 2022: $172 · 2023: $22.91 · 2024: $140 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $268.51 | 2024-2025 | (5044) Mcot, Mcot |
| Actelion Pharmaceuticals US, INC. | $243.66 | 2022-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $220.16 | 2019-2023 | |
| Abbott Laboratories | $186.46 | 2025 | Triclip |
| Pfizer INC. | $182.13 | 2019 | |
| Amgen INC. | $128.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $93.86 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $77.15 | 2019 | |
| Amarin Pharma, INC. | $58.09 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.69 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $38.03 | 2019 | |
| Biotronik INC. | $26.29 | 2022 | |
| Braemar Manufacturing, LLC | $21.79 | 2019 | |
| Irhythm Technologies, INC. | $21.06 | 2019 | |
| Medtronic USA, INC. | $19.01 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.42 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.20 | 2019 | |
| Vanda Pharmaceuticals INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.